Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience
dc.contributor.author | Gemici, Aliihsan | |
dc.contributor.author | Aydogdu, Ismet | |
dc.contributor.author | Terzi, Hatice | |
dc.contributor.author | Sencan, Mehmet | |
dc.contributor.author | Aslan, Alma | |
dc.contributor.author | Kaya, Ali Hakan | |
dc.contributor.author | Dal, Mehmet Sinan | |
dc.contributor.author | Akay, Meltem Olga | |
dc.contributor.author | Dogu, Mehmet Hilmi | |
dc.contributor.author | Ayyildiz, Orhan | |
dc.contributor.author | Sahin, Fahri | |
dc.contributor.author | Cagliyan, Gulsum Akgun | |
dc.contributor.author | Yilmaz, Mehmet | |
dc.contributor.author | Gokgoz, Zafer | |
dc.contributor.author | Bilen, Yusuf | |
dc.contributor.author | Demir, Cengiz | |
dc.contributor.author | Sevindik, Omur Gokmen | |
dc.contributor.author | Korkmaz, Serdal | |
dc.contributor.author | Eser, Bulent | |
dc.contributor.author | Altuntas, Fevzi | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T09:38:38Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T09:38:38Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 0278-0232 | |
dc.identifier.issn | 1099-1069 | |
dc.identifier.uri | https://dx.doi.org/10.1002/hon.2460 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/6381 | |
dc.description | WOS: 000425633300017 | en_US |
dc.description | PubMed ID: 28707314 | en_US |
dc.description.abstract | Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) is a rare subtype of Hodgkin's lymphoma. In this study, we aimed to investigate the clinical features and therapeutic outcomes of patients with NLPHL who were diagnosed at different institutes in Turkey. We retrospectively reviewed the records of the patients diagnosed with NLPHL. Adult patients who were diagnosed after 2005 with histological confirmation were selected for the study. Forty-three patients were included in the study. Median age of patients was 37.5years (18-70) at the time of diagnosis. About 60.5% patients were diagnosed as stage I and II NLPHL, and remaining 39.5% had stage III and IV disease. Median follow-up was 46months. During follow-up, none of the patients died. Seven patients relapsed or progressed after initial therapy at a median of 12months. Five of 7 relapsed/refractory patients (71.4%) were salvaged with chemotherapy only (DHAP, ICE), and the remaining 2 (28.6%) were salvaged with chemoimmunotherapy. All of relapsed/refractory patients were able to achieve complete remission after salvage therapy. Lactate dehydrogenase levels were significantly higher in patients with progressive disease compared with nonprogressive disease. Our study showed an excellent outcome with all patients alive at last contact with a median follow up of 46months despite a wide range of different therapeutic approaches. All relapsed and refractory patients were successfully salvaged despite a low frequency of patients received immunotherapy in conjunction with chemotherapy. Our results suggest that immunotherapy may be reserved for further relapses. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | WILEY | en_US |
dc.relation.isversionof | 10.1002/hon.2460 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | nodular lymphocyte predominant Hodgkin's lymphoma | en_US |
dc.subject | overall survival | en_US |
dc.subject | progression-free survival | en_US |
dc.subject | treatment | en_US |
dc.title | Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience | en_US |
dc.type | article | en_US |
dc.relation.journal | HEMATOLOGICAL ONCOLOGY | en_US |
dc.contributor.department | [Gemici, Aliihsan] Sanliurfa Mehmet AkifInan Training & Res Hosp, Div Hematol, Sanliurfa, Turkey -- [Aydogdu, Ismet] Celal Bayar Univ, Dept Hematol, Manisa, Turkey -- [Terzi, Hatice -- Sencan, Mehmet] Cumhuriyet Univ, Dept Hematol, Sivas, Turkey -- [Aslan, Alma] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey -- [Kaya, Ali Hakan -- Dal, Mehmet Sinan -- Altuntas, Fevzi] Ankara Oncol Training & Res Hosp, Hematol & Stem Cell Transplantat Clin, Ankara, Turkey -- [Akay, Meltem Olga] Osmangazi Univ, Dept Hematol, Eskisehir, Turkey -- [Dogu, Mehmet Hilmi] Istanbul Training & Res Hosp, Div Hematol, Istanbul, Turkey -- [Ayyildiz, Orhan] Dicle Univ, Dept Hematol, Diyarbakir, Turkey -- [Sahin, Fahri] Ege Univ, Dept Hematol, Izmir, Turkey -- [Cagliyan, Gulsum Akgun] Denizli State Hosp, Div Hematol, Denizli, Turkey -- [Yilmaz, Mehmet] Gaziantep Univ, Dept Hematol, Gaziantep, Turkey -- [Gokgoz, Zafer] Ordu State Hosp, Div Hematol Ordu, Ordu, Turkey -- [Bilen, Yusuf] Ataturk Univ, Dept Hematol, Erzurum, Turkey -- [Demir, Cengiz] Yuzuncu Yil Univ, Dept Hematol, Van, Turkey -- [Sevindik, Omur Gokmen] Firat Univ, Dept Hematol, Elazig, Turkey -- [Korkmaz, Serdal] Kayseri Training & Res Hosp, Div Hematol, Kayseri, Turkey -- [Eser, Bulent] Erciyes Univ, Dept Hematol, Kayseri, Turkey | en_US |
dc.contributor.authorID | Altuntas, Fevzi -- 0000-0001-6872-3780 | en_US |
dc.identifier.volume | 36 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.endpage | 120 | en_US |
dc.identifier.startpage | 116 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Makale Koleksiyonu [5200]
Article Collection -
Makale Koleksiyonu [5745]
Article Collection -
Öksüz Yayınlar Koleksiyonu - WoS [6162]